Source: Beta | Wednesday, 07.05.2014.| 13:26
Highlight an article Print out the news

Bayer to buy part of U.S. pharmaceutical companny Merck for USD 14.2 billion

(Photo: Ivana Vuksa)
The German drug maker Bayer plans to acquire Merck's consumer care business for $14.2 billion, a deal that will make Bayer one of the largest providers of over-the-counter products, giving this company control of several well-known brand names, including Claritin, Coppertone and Dr. Scholl’s.

Bayer Chief Executive Marijn Dekkers said Tuesday that the proposed agreement represented "a big landmark on the company's path to becoming a global leader in attracting the companies that produce over-the-counter drugs".

Bayer announced that this acquisition would make it a leader in North and South America when it comes to over-the-counter retail products.

This company already owns some main OTC brands such as painkillers Alev and Alka-Selcer and the vitamin One-a-day.

Only logged-in users can comment.
Follow the news, tenders, grants, legal regulations and reports on our portal.
Testiraj besplatno!
Register for our daily business bulletin, which is sent to your email address at the end of each work day.
Full information is available only to commercial users-subscribers and it is necessary to log in.
Test for free!
Testiraj besplatno!
Full information is available to commercial users-subscribers only.
Testiraj besplatno!

Log in to view complete information:
Forgot your password? Click here HERE
For free test use, click HERE